Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-03-05

FDA Approved: ALISKIREN — Original Application (Prasco Laboratories)

View source ↗

Summary

FDA approved Prasco Laboratories' original application for aliskiren hemifumarate, a direct renin inhibitor, for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)

Snippet

ORIG AP for ALISKIREN (ALISKIREN HEMIFUMARATE)